COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation, Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/3/2018 |
| Start Date: | May 17, 2017 |
| End Date: | November 30, 2017 |
The objective of this study is to conduct a randomized controlled trial to determine whether
the use of the COach2Quit application (app) reduces smoking more than brief advice for
smoking cessation. The investigators hypothesize that real time biomarker feedback and
messaging support from the COach2Quit app will lead to greater smoking cessation rates than
brief anti-smoking advice alone. If effective, the COach2Quit app could be an easily
accessible and cost-effective tool to help smokers quit. The findings from this trial could
have implications for the delivery of future outpatient smoking cessation programs.
the use of the COach2Quit application (app) reduces smoking more than brief advice for
smoking cessation. The investigators hypothesize that real time biomarker feedback and
messaging support from the COach2Quit app will lead to greater smoking cessation rates than
brief anti-smoking advice alone. If effective, the COach2Quit app could be an easily
accessible and cost-effective tool to help smokers quit. The findings from this trial could
have implications for the delivery of future outpatient smoking cessation programs.
The goal of this randomized controlled trial is to assess the efficacy of the novel
COach2Quit smartphone application by determining whether the use of this app reduces smoking
more than brief anti-smoking advice alone. This will be a two-arm individually randomized
trial and participants who are currently smoking will be assigned 1:1 to either study arm.
Smoking behavior will be measured through self-report at baseline, 2-week and 1-month follow
up visits. Smoking behavior will also be verified by 2 biomarker measurements: carbon
monoxide breath test and urine cotinine, collected at baseline, 2-week and 1-month follow-up
visits. In addition, participants will receive weekly follow-up calls. The primary outcome
will be smoking cessation at the 1-month follow-up visit.
COach2Quit smartphone application by determining whether the use of this app reduces smoking
more than brief anti-smoking advice alone. This will be a two-arm individually randomized
trial and participants who are currently smoking will be assigned 1:1 to either study arm.
Smoking behavior will be measured through self-report at baseline, 2-week and 1-month follow
up visits. Smoking behavior will also be verified by 2 biomarker measurements: carbon
monoxide breath test and urine cotinine, collected at baseline, 2-week and 1-month follow-up
visits. In addition, participants will receive weekly follow-up calls. The primary outcome
will be smoking cessation at the 1-month follow-up visit.
Inclusion Criteria:
- ≥18 years of age
- current, daily smokers
- agree to participate and anticipate to be living in Baltimore for at least 2 months
- own a phone that is compatible with the app
- be willing to set at baseline assessment a quit date within 2 weeks
Exclusion Criteria:
- are suffering from any unstable medical condition precluding the use of the CO monitor
(e.g. severe COPD)
- are currently using smokeless tobacco including e-cigarettes
- are currently using nicotine replacement therapy or other smoking cessation treatment
- are pregnant, determined by participant self-report
- have a negative baseline result on both urine cotinine AND CO monitor
We found this trial at
1
site
733 North Broadway
Baltimore, Maryland 21205
Baltimore, Maryland 21205
(410) 955-3182
Johns Hopkins University School of Medicine Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is...
Click here to add this to my saved trials
